Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05976490

NeuroPathways Intervention for Brain Tumor Patients

NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.

Detailed description

This study will be a prospective pilot randomized controlled trial to examine the feasibility and acceptability of a novel, population-specific intervention designed to help patients with recently-diagnosed malignant brain tumors process and cope with their illness. The specific aims are to 1) refine the NeuroPathways intervention based on feedback from an open pilot study (n=up to 10) with exit interviews, 2) evaluate the feasibility and acceptability of NeuroPathways in a pilot randomized controlled trial (n=40), and 3) explore preliminary effects of the intervention on psychological, behavioral, and cognitive outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInformation and Support InterventionInformation guide and four one-on-one coaching sessions
OTHERUsual supportive careReferral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician

Timeline

Start date
2023-11-07
Primary completion
2026-09-10
Completion
2027-04-10
First posted
2023-08-04
Last updated
2025-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05976490. Inclusion in this directory is not an endorsement.